EXCLUSIVE

Home visits = regulatory thumbs up? ResearchNurses.co thinks so

By Natalie Morrison

- Last updated on GMT

Related tags: Patient

The use of home visits in clinical trials could raise the chances of regulatory approval, according to ResearchNurses.co.

In the second part of an exclusive podcast with Outsourcing-Pharma (listen to yesterday’s podcast here​) Sue Mackay said that the levels of compliance offered by having a healthcare professional give drugs to patients who would otherwise self-administer is a big plus for the authorities.

“The dosage will be correct,”​ the research nursing team manager said. “So from a regulatory perspective – I think they would probably quite like that.”

She added that for data collection and monitoring, home visits are a way to boost accuracy.

Mackay also said that the regulators are currently putting an increasing focus on patient retention, something she believes home visits can help with because it is more “flexible” ​for the patient, and provides them with a personalised point of contact.

“It’s becoming a bigger issue for companies to try to maintain levels of recruitment in studies,”​ she said.

“I think the regulatory bodies both in the states and here in the UK and Europe and Asia, are looking at is ‘what would make a patient want to be in this study, and stay in this study?’”

Related news

Show more

Related products

show more

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Parents as Gatekeepers for Children with Cancer

Parents as Gatekeepers for Children with Cancer

PRA Health Sciences | 08-Jun-2020 | Technical / White Paper

The RACE for Children Act will require new drugs intended for adult cancer treatment to also be studied in pediatric cancers when the molecular target...

Related suppliers

Follow us

Products

View more

Webinars